Loading...
Market
CEO of Pfizer at end of 2025?
4
Resolution / Starting Odds
Albert Bourla • 25%
Ian Read • 25%
Frank D'Amelio • 25%
Other • 25%
Official announcements from Pfizer or credible news outlets
Story
Ex-Pfizer Execs Quit Starboard's $1 Billion Campaign, Now Back CEO Bourla Amid Legal Threats
Oct 10, 2024, 12:39 PM
Former Pfizer CEO Ian Read and former CFO Frank D'Amelio have withdrawn their support for activist investor Starboard Value's campaign against the pharmaceutical company. Starboard, which has invested $1 billion in Pfizer, had been collaborating with Read and D'Amelio to push for changes, including possibly replacing CEO Albert Bourla, who had steered Pfizer through the COVID-19 crisis and momentarily past a $100 billion market cap. The two former executives issued a statement expressing full support for Bourla and the company's senior management and board. Following their reversal, Starboard accused Pfizer of threatening to sue the former executives to force their withdrawal and sent a letter to Pfizer's board calling for a special committee to investigate potential breaches of fiduciary duty and alleged coercive conduct. Pfizer's stock fell 1% amid the unfolding dispute.
View original story
Similar markets
Albert Bourla • 25%
Current Pfizer executive • 25%
External candidate • 25%
Other • 25%
Boehringer Ingelheim • 25%
AstraZeneca • 25%
Another major pharmaceutical company • 25%
A biotech startup • 25%
Internal candidate • 25%
External candidate from a major pharmaceutical company • 25%
External candidate from a biotech startup • 25%
Other • 25%
Tim Wentworth • 25%
John Standley • 25%
Rosalind Brewer • 25%
Other • 25%
Less than $150 billion • 25%
$150 billion to $170 billion • 25%
$170 billion to $190 billion • 25%
More than $190 billion • 25%
Executive A • 25%
Executive B • 25%
Both • 25%
Neither • 25%
Pascal Soriot • 25%
New CEO • 25%
Interim CEO • 25%
Other • 25%